A study co-led by UCLA scientists has found targeting a protein called endocan and its related signaling pathway could be a promising new approach for treating glioblastoma, an aggressive and lethal type of brain cancer.
Zyme Communications expands UK head office with new facilities at Cambridge Innovation Park
Zyme Communications Ltd., life science specialist PR and marketing agency, today announced the expansion of its UK headquarters with a move to larger office premises